Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2618261000168113 | Mylanta 2go Original (aluminium hydroxide 200 mg + magnesium hydroxide 200 mg + simethicone 20 mg) chewable tablet, 4 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2618271000168119 | Mylanta 2go Original chewable tablet, 4 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mylanta 2go Original chewable tablet, 4 | Is a | aluminium hydroxide 200 mg + magnesium hydroxide 200 mg + simethicone 20 mg chewable tablet, 4 | true | Inferred relationship | Some | ||
| Mylanta 2go Original chewable tablet, 4 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Mylanta 2go Original chewable tablet, 4 | has TPUU | Mylanta 2go Original chewable tablet | true | Inferred relationship | Some | 1 | |
| Mylanta 2go Original chewable tablet, 4 | has TP | Mylanta 2go Original | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mylanta 2go Original (aluminium hydroxide 200 mg + magnesium hydroxide 200 mg + simethicone 20 mg) chewable tablet, 4 tablets, blister pack (containered trade product pack) | Is a | True | Mylanta 2go Original chewable tablet, 4 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR